Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;17(1):45-57.
doi: 10.5863/1551-6776-17.1.45.

Treatment of obesity in children and adolescents

Kelly L Matson  1 , Renee M Fallon
Affiliations

Treatment of obesity in children and adolescents

Kelly L Matson et al. J Pediatr Pharmacol Ther. 2012 Jan.

Abstract

The prevalence of childhood and adolescent obesity continues to rise in the United States (US). Immediate health consequences are being observed, and long-term risks are mounting within the pediatric population, secondary to obesity. The hallmark of prevention and treatment of obesity in children and adolescents includes lifestyle modification (i.e., dietary modification, increased physical activity, and behavioral modifications). However, when intensive lifestyle modification is insufficient to reach weight loss goals, adjunctive pharmacotherapy is recommended. Among the group of weight-loss medications, orlistat is the only US Food and Drug Administration (FDA)-approved prescription drug for the treatment of overweight and obese adolescents. Other medications, including metformin, need larger studies to establish their role in treatment. No single approach to management of pediatric obesity is the answer, given the complexity of the disorder and the many reasons for failure. Evidence of weight loss medications in addition to lifestyle modification supports short-term efficacy for treatment of obese children and adolescents, although long-term results remain unclear.

Keywords: adolescents; children; obese; obesity; overweight.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention US Department of Health and Human Services. Overweight and Obesity. 2011 http://www.cdc.gov/obesity/index.html. Accessed November 19.
    1. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303(3):242–249. - PubMed
    1. Gaziano JM. Fifth phase of the epidemiologic transition. JAMA. 2010;303(3):275–276. - PubMed
    1. August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93(12):4576–4599. - PMC - PubMed
    1. American Academy of Pediatrics Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics. 2003;112(2):424–430. - PubMed

LinkOut - more resources